Si-Bone (SIBN) Income towards Parent Company (2017 - 2026)
Si-Bone's (SIBN) quarterly Income towards Parent Company came in at -$18.4 million in Q1 2026, down 180.81% year-on-year from $22.8 million in Q1 2025, and down 1017.44% quarter-over-quarter from -$1.6 million in Q4 2025.
Si-Bone (SIBN) Income towards Parent Company (2017 - 2026) Analysis & Trends
Si-Bone's Income towards Parent Company history runs 10 years deep, the most recent figure standing at -$18.4 million for Q1 2026.
- On a quarterly basis, Income towards Parent Company fell 180.81% year-over-year to -$18.4 million in Q1 2026; TTM through Mar 2026 was -$5.4 billion, a 19199.97% decrease from a year earlier, with the FY2025 full-year figure at -$127.4 million, up 9.39% from the prior year.
- Income towards Parent Company slipped to -$18.4 million in Q1 2026 per SIBN's latest filing, from -$1.6 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$1.6 million in Q4 2025 and bottomed at -$5.4 billion in Q3 2025.
- The 5-year median for Income towards Parent Company is -$11.2 million (2023), against an average of -$326.0 million.
- Biggest YoY gain for Income towards Parent Company was 72.03% in 2025; the steepest drop was 81390.17% in 2025.
- Year by year, Income towards Parent Company stood at -$12.2 million in 2022, then declined by 1.17% to -$12.3 million in 2023, then soared by 52.17% to -$5.9 million in 2024, then surged by 72.03% to -$1.6 million in 2025, then tumbled by 1017.44% to -$18.4 million in 2026.
- Per Business Quant, the three latest SIBN Income towards Parent Company figures stand at -$18.4 million (Q1 2026), -$1.6 million (Q4 2025), and -$5.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Si-Bone | 753.03 Mn | 608.35 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.39 Mn |
| Dec 31, 2025 | -1.65 Mn |
| Sep 30, 2025 | -5.36 Bn |
| Jun 30, 2025 | -13.17 Mn |
| Mar 31, 2025 | -6.55 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Sep 30, 2024 | -6.58 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -10.81 Mn |
| Dec 31, 2023 | -12.31 Mn |
| Sep 30, 2023 | -9.88 Mn |
| Jun 30, 2023 | -11.23 Mn |
| Mar 31, 2023 | -11.20 Mn |
| Dec 31, 2022 | -12.16 Mn |
| Sep 30, 2022 | -13.98 Mn |
| Jun 30, 2022 | -18.37 Mn |
| Mar 31, 2022 | -17.36 Mn |
| Dec 31, 2021 | -18.43 Mn |
| Sep 30, 2021 | -15.81 Mn |
| Jun 30, 2021 | -13.99 Mn |